SARM1 activation triggers axon degeneration locally via NAD + destruction

Programmed Cell Death in Animal Development and Disease

Fuchs, Y., & Steller, H. (2011) · Cell · doi:10.1016/j.cell.2011.10.033 · Cited by 1,915 · see citing works

Increased Nuclear NAD Biosynthesis and SIRT1 Activation Prevent Axonal Degeneration

Araki, T., Sasaki, Y., & Milbrandt, J. (2004) · Science · doi:10.1126/science.1098014 · Cited by 1,060 · see citing works

Poly(ADP-ribosyl)ation by PARP-1: `PAR-laying' NAD + into a nuclear signalPreprint

Kim, M. Y., Zhang, T., & Kraus, W. L. (2005) · Genes & Development · doi:10.1101/gad.1331805 · Cited by 803 · see citing works

dSarm/Sarm1 Is Required for Activation of an Injury-Induced Axon Death Pathway

Osterloh, J. M., Yang, J. H., Rooney, T. M., Fox, A. N., Adalbert, R., Powell, E. H., Sheehan, A. E., Avery, M. A., Hackett, R., Logan, M. A., et al. (2012) · Science · doi:10.1126/science.1223899 · Cited by 688 · see citing works

Wallerian degeneration: an emerging axon death pathway linking injury and disease

Conforti, L., Gilley, J., & Coleman, M. P. (2014) · Nature reviews. Neuroscience · doi:10.1038/nrn3680 · Cited by 611 · see citing works

The Toll–IL-1 receptor adaptor family grows to five members

O'Neill, L. A. J., Fitzgerald, K. A., & Bowie, A. G. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00115-7 · Cited by 492 · see citing works

Sarm1-Mediated Axon Degeneration Requires Both SAM and TIR Interactions

Gerdts, J., Summers, D. W., Sasaki, Y., DiAntonio, A., & Milbrandt, J. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1197-13.2013 · Cited by 375 · see citing works

Regulation of intracellular levels of NAD: A novel role for CD38

Aksoy, P., White, T. A., Thompson, M., & Chini, E. N. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.05.042 · Cited by 353 · see citing works

A local mechanism mediates NAD-dependent protection of axon degeneration

Wang, J., Zhai, Q., Chen, Y., Lin, E., Gu, W., McBurney, M. W., & He, Z. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200504028 · Cited by 352 · see citing works

Structural Biology of the Toll-Like Receptor Family

Kang, J. Y., & Lee, J. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-052909-141507 · Cited by 331 · see citing works

Pathways and Subcellular Compartmentation of NAD Biosynthesis in Human Cells

Nikiforov, A., Dölle, C., Niere, M., & Ziegler, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.213298 · Cited by 326 · see citing works

Chemically Controlled Protein Assembly: Techniques and Applications

Fegan, A., White, B., Carlson, J., & Wagner, C. R. (2010) · Chemical Reviews · doi:10.1021/cr8002888 · Cited by 296 · see citing works

Monitoring regulated protein-protein interactions using split TEV

Wehr, M. C., Laage, R., Bolz, U., Fischer, T. M., Grünewald, S., Scheek, S., Bach, A., Nave, K., & Rossner, M. J. (2006) · Nature Methods · doi:10.1038/nmeth967 · Cited by 278 · see citing works

Protein turnover of the Wallenda/DLK kinase regulates a retrograde response to axonal injury

Xiong, X., Wang, X., Ewanek, R., Bhat, P., DiAntonio, A., & Collins, C. A. (2010) · The Journal of Cell Biology · doi:10.1083/jcb.201006039 · Cited by 275 · see citing works

Stimulation of Nicotinamide Adenine Dinucleotide Biosynthetic Pathways Delays Axonal Degeneration after Axotomy

Sasaki, Y., Araki, T., & Milbrandt, J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2320-06.2006 · Cited by 269 · see citing works

Nicotinamide Mononucleotide Adenylyl Transferase-Mediated Axonal Protection Requires Enzymatic Activity But Not Increased Levels of Neuronal Nicotinamide Adenine Dinucleotide

Sasaki, Y., Vohra, B., Lund, F., & Milbrandt, J. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.5469-08.2009 · Cited by 254 · see citing works

P7C3 Neuroprotective Chemicals Function by Activating the Rate-Limiting Enzyme in NAD Salvage

Wang, G., Han, T., Nijhawan, D., Theodoropoulos, P., Naidoo, J., Yadavalli, S., Mirzaei, H., Pieper, A. A., Ready, J. M., & McKnight, S. L. (2014) · Cell · doi:10.1016/j.cell.2014.07.040 · Cited by 243 · see citing works

MyD88-5 links mitochondria, microtubules, and JNK3 in neurons and regulates neuronal survival

Kim, Y., Zhou, P., Qian, L., Chuang, J.-Z., Lee, J., Li, C., Iadecola, C., Nathan, C., & Ding, A. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070868 · Cited by 234 · see citing works

An 85-kb tandem triplication in the slow Wallerian degeneration ( Wld s ) mouse

Coleman, M. P., Conforti, L., Buckmaster, E. A., Tarlton, A., Ewing, R. M., Brown, M. C., Lyon, M. F., & Perry, V. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.9985 · Cited by 188 · see citing works

Mitochondrial Dysfunction Induces Sarm1-Dependent Cell Death in Sensory Neurons

Summers, D. W., DiAntonio, A., & Milbrandt, J. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0877-14.2014 · Cited by 176 · see citing works

Activation of the Innate Signaling Molecule MAVS by Bunyavirus Infection Upregulates the Adaptor Protein SARM1, Leading to Neuronal Death

Mukherjee, P., Woods, T. A., Moore, R. A., & Peterson, K. E. (2013) · Immunity · doi:10.1016/j.immuni.2013.02.013 · Cited by 140 · see citing works

Accurate Measurement of Nicotinamide Adenine Dinucleotide (NAD+) with High-Performance Liquid Chromatography

Yoshino, J., & Imai, S. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-637-5_14 · Cited by 95 · see citing works

T-cell death following immune activation is mediated by mitochondria-localized SARM

Panneerselvam, P., Singh, L. P., Selvarajan, V., Chng, W. J., Ng, S., Tan, N. S., Ho, B., Chen, J., & Ding, J. L. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.144 · Cited by 85 · see citing works

Control of Nonapoptotic Developmental Cell Death in Caenorhabditis elegans by a Polyglutamine-Repeat Protein

Blum, E. S., Abraham, M. C., Yoshimura, S., Lu, Y., & Shaham, S. (2012) · Science · doi:10.1126/science.1215156 · Cited by 70 · see citing works

Axonal degeneration is blocked by nicotinamide mononucleotide adenylyltransferase (NMNAT) protein transduction into transected axons

Sasaki, Y., & Milbrandt, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.c110.193904 · Cited by 66 · see citing works

Image-based Screening Identifies Novel Roles for IκB Kinase and Glycogen Synthase Kinase 3 in Axonal Degeneration

Gerdts, J., Sasaki, Y., Vohra, B. P. S., Marasa, J. C., & Milbrandt, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.250472 · Cited by 65 · see citing works

Electrotransfer of [32P]NAD allows labeling of ADP-ribosylated proteins in intact Chinese hamster ovary cells

Elia, M. C., Motyka, L. E., & Stamato, T. D. (1991) · Analytical Biochemistry · doi:10.1016/0003-2697(91)90544-4 · Cited by 4 · see citing works

NAD+ Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus

Cantó, C., Menzies, K. J., & Auwerx, J. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.023 · Cited by 1,648 · see citing works

NAD+ metabolism and its roles in cellular processes during ageing

Covarrubias, A. J., Perrone, R., Grozio, A., & Verdin, E. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00313-x · Cited by 1,617 · see citing works

Neuronal Cell Death

Fricker, M., Tolkovsky, A. M., Borutaitė, V., Coleman, M. P., & Brown, G. C. (2018) · Physiological Reviews · doi:10.1152/physrev.00011.2017 · Cited by 1,122 · see citing works

NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential

Xie, N., Zhang, L., Gao, W. Q., Huang, C., Huber, P., Zhou, X., Li, C. L., Shen, G., & Zou, B. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00311-7 · Cited by 1,076 · see citing works

Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence

Rajman, L., Chwalek, K., & Sinclair, D. A. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.011 · Cited by 865 · see citing works

Slowing ageing by design: the rise of NAD+ and sirtuin-activating compounds

Bonkowski, M. S., & Sinclair, D. A. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.93 · Cited by 834 · see citing works

NAD+ in Brain Aging and Neurodegenerative Disorders

Lautrup, S., Sinclair, D. A., Mattson, M. P., & Fang, E. F. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.09.001 · Cited by 790 · see citing works

The SARM1 toll/interleukin-1 receptor domain possesses intrinsic NAD(+) cleavage activity that promotes pathological axonal degeneration

Essuman, K., Summers, D. W., Sasaki, Y., Mao, X., DiAntonio, A., & Milbrandt, J. (2017) · Neuron · doi:10.1016/j.neuron.2017.02.022 · Cited by 619 · see citing works

NAD+ homeostasis in health and disease

Katsyuba, E., Romani, M., Hofer, D., & Auwerx, J. (2020) · Nature Metabolism · doi:10.1038/s42255-019-0161-5 · Cited by 627 · see citing works

NAD + cleavage activity by animal and plant TIR domains in cell death pathways

Horsefield, S., Burdett, H., Zhang, X., Manik, M. K., Shi, Y. Y., Chen, J., Qi, T., Gilley, J., Lai, J., Rank, M. X., et al. (2019) · Science · doi:10.1126/science.aax1911 · Cited by 474 · see citing works

Sirtuins and NAD + in the Development and Treatment of Metabolic and Cardiovascular Diseases

Kane, A. E., & Sinclair, D. A. (2018) · Circulation Research · doi:10.1161/circresaha.118.312498 · Cited by 490 · see citing works

TIR domains of plant immune receptors are NAD + -cleaving enzymes that promote cell death

Wan, L., Essuman, K., Anderson, R. G., Sasaki, Y., Monteiro, F., Chung, E., Nishimura, E. O., DiAntonio, A., Milbrandt, J., Dangl, J. L., et al. (2019) · Science · doi:10.1126/science.aax1771 · Cited by 464 · see citing works

Dynamic Axonal Translation in Developing and Mature Visual Circuits

Shigeoka, T., Jung, H., Jung, J., Turner-Bridger, B., Ohk, J., Lin, J. Q., Amieux, P. S., & Holt, C. E. (2016) · Cell · doi:10.1016/j.cell.2016.05.029 · Cited by 458 · see citing works

Role of NAD+ in regulating cellular and metabolic signaling pathways

Amjad, S., Nisar, S., Bhat, A. A., Shah, A. R., Frenneaux, M. P., Fakhro, K. A., Haris, M., Reddy, R. D., Patay, Z. J., Baur, J. A., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101195 · Cited by 394 · see citing works

SARM1 is a metabolic sensor activated by an increased NMN/NAD+ ratio to trigger axon degeneration

Figley, M. D., Gu, W., Nanson, J. D., Shi, Y., Sasaki, Y., Cunnea, K., Malde, A. K., Jia, X., Luo, Z., Saikot, F. K., et al. (2021) · Neuron · doi:10.1016/j.neuron.2021.02.009 · Cited by 324 · see citing works

Programmed axon degeneration: from mouse to mechanism to medicine

Coleman, M. P., & Höke, A. (2020) · Nature reviews. Neuroscience · doi:10.1038/s41583-020-0269-3 · Cited by 320 · see citing works

Axon Self-Destruction: New Links among SARM1, MAPKs, and NAD+ Metabolism

Gerdts, J., Summers, D. W., Milbrandt, J., & DiAntonio, A. (2016) · Neuron · doi:10.1016/j.neuron.2015.12.023 · Cited by 318 · see citing works

Central nervous system regeneration

Varadarajan, S. G., Hunyara, J. L., Hamilton, N. R., Kolodkin, A. L., & Huberman, A. D. (2022) · Cell · doi:10.1016/j.cell.2021.10.029 · Cited by 312 · see citing works

Nicotinamide Riboside Opposes Type 2 Diabetes and Neuropathy in Mice

Trammell, S. A. J., Weidemann, B. J., Chadda, A., Yorek, M. S., Holmes, A., Coppey, L. J., Obrosov, A., Kardon, R. H., Yorek, M. A., & Brenner, C. (2016) · Scientific Reports · doi:10.1038/srep26933 · Cited by 301 · see citing works

Traumatic Axonal Injury: Mechanisms and Translational Opportunities

Hill, C., Coleman, M., & Menon, D. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.03.002 · Cited by 312 · see citing works

NAD+ homeostasis in renal health and disease

Ralto, K. M., Rhee, E. P., & Parikh, S. M. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0216-6 · Cited by 288 · see citing works

Evolving concepts in NAD+ metabolism

Chini, C. C. S., Zeidler, J. D., Kashyap, S., Warner, G. M., & Chini, E. N. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.04.003 · Cited by 294 · see citing works

Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice

Geisler, S., Doan, R. A., Strickland, A. M., Huang, X., Milbrandt, J., & DiAntonio, A. (2016) · Brain · doi:10.1093/brain/aww251 · Cited by 272 · see citing works

The Axon-Myelin Unit in Development and Degenerative Disease

Stassart, R. M., Möbius, W., Nave, K.-A., & Edgar, J. M. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00467 · Cited by 246 · see citing works

The synapse in traumatic brain injury

Jamjoom, A. A. B., Rhodes, J. K. J., Andrews, P., & Grant, S. G. N. (2020) · Brain · doi:10.1093/brain/awaa321 · Cited by 243 · see citing works

TIR Domain Proteins Are an Ancient Family of NAD+-Consuming Enzymes

Essuman, K., Summers, D. W., Sasaki, Y., Mao, X. R., Yim, A. K., DiAntonio, A., & Milbrandt, J. (2018) · Current Biology · doi:10.1016/j.cub.2017.12.024 · Cited by 234 · see citing works

The Pharmacology of CD38/NADase: An Emerging Target in Cancer and Diseases of Aging

Chini, E. N., Chini, C. C. S., Espindola Netto, J. M., de Oliveira, G. C., & van Schooten, W. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.02.001 · Cited by 227 · see citing works

Modulating NAD+ metabolism, from bench to bedside

Katsyuba, E., & Auwerx, J. H. (2017) · The EMBO Journal · doi:10.15252/embj.201797135 · Cited by 224 · see citing works

Nicotinamide Riboside—The Current State of Research and Therapeutic Uses

Mehmel, M., Jovanović, N. D., & Spitz, U. P. (2020) · Nutrients · doi:10.3390/nu12061616 · Cited by 225 · see citing works

Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction

Tribble, J. R., Otmani, A., Sun, S., Ellis, S. A., Cimaglia, G., Vohra, R., Jöe, M., Lardner, E., Venkataraman, A. P., Domínguez‐Vicent, A., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101988 · Cited by 233 · see citing works

NAD and the aging process: role in life, death and everything in between

Chini, C. C. S., Tarragó, M. G., & Chini, E. N. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.11.003 · Cited by 208 · see citing works

Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults

Conze, D., Brenner, C., & Kruger, C. L. (2019) · Scientific Reports · doi:10.1038/s41598-019-46120-z · Cited by 210 · see citing works

NMNAT1 inhibits axon degeneration via blockade of SARM1-mediated NAD+ depletion

Sasaki, Y., Nakagawa, T., Mao, X., DiAntonio, A., & Milbrandt, J. (2016) · eLife · doi:10.7554/elife.19749 · Cited by 192 · see citing works

A Mechanistic Understanding of Axon Degeneration in Chemotherapy-Induced Peripheral Neuropathy

Fukuda, Y., Li, Y., & Segal, R. A. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00481 · Cited by 206 · see citing works

The NAD+-mediated self-inhibition mechanism of pro-neurodegenerative SARM1

Jiang, Y., Liu, T., Lee, C., Chang, Q., Yang, J. H., & Zhang, Z. (2020) · Nature · doi:10.1038/s41586-020-2862-z · Cited by 199 · see citing works

The Influence of Nicotinamide on Health and Disease in the Central Nervous System

Fricker, R. A., Green, E. L., Jenkins, S. I., & Griffin, S. M. (2018) · International Journal of Tryptophan Research · doi:10.1177/1178646918776658 · Cited by 200 · see citing works

Pathomechanisms of Paclitaxel-Induced Peripheral Neuropathy

Klein, I., & Lehmann, H. C. (2021) · Toxics · doi:10.3390/toxics9100229 · Cited by 198 · see citing works

Attenuated traumatic axonal injury and improved functional outcome after traumatic brain injury in mice lacking Sarm1

Henninger, N., Bouley, J., Şıkoğlu, E. M., An, J., Moore, C. M., King, J. A., Bowser, R. P., Freeman, M. R., & Brown, R. H. (2016) · Brain · doi:10.1093/brain/aww001 · Cited by 189 · see citing works

NOD-like receptor-mediated plant immunity: from structure to cell death

Saur, I. M. L., Panstruga, R., & Schulze‐Lefert, P. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-020-00473-z · Cited by 197 · see citing works

NAMPT-Mediated NAD+ Biosynthesis Is Essential for Vision In Mice

Lin, J. B., Kubota, S., Ban, N., Yoshida, M., Santeford, A. C., Sène, A., Nakamura, R. E. I., Zapata, N., Kubota, M., Tsubota, K., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.073 · Cited by 185 · see citing works

Small Molecule SARM1 Inhibitors Recapitulate the SARM1−/− Phenotype and Allow Recovery of a Metastable Pool of Axons Fated to Degenerate

Hughes, R. O., Bosanac, T., Mao, X. R., Engber, T. M., DiAntonio, A., Milbrandt, J., Devraj, R. V., & Krauss, R. (2021) · Cell Reports · doi:10.1016/j.celrep.2020.108588 · Cited by 186 · see citing works

Recent Advances in Effector-Triggered Immunity in Plants: New Pieces in the Puzzle Create a Different Paradigm

Nguyen, Q., Iswanto, A. B. B., Son, G. H., & Kim, S. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094709 · Cited by 183 · see citing works

Axonal Degeneration during Aging and Its Functional Role in Neurodegenerative Disorders

Salvadores, N., Sanhueza, M., Manque, P., & Court, F. A. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00451 · Cited by 182 · see citing works

Deletion of Sarm1 gene is neuroprotective in two models of peripheral neuropathy

Turkiew, E., Falconer, D., Reed, N., & Höke, A. (2017) · Journal of the Peripheral Nervous System · doi:10.1111/jns.12219 · Cited by 182 · see citing works

A Cell-Permeant Mimetic of NMN Activates SARM1 to Produce Cyclic ADP-Ribose and Induce Non-apoptotic Cell Death

Zhao, Z. Y., Xie, X. J., Li, W. H., Liu, J., Chen, Z., Zhang, B., Li, T., Li, S. L., Lu, J. G., Zhang, L., et al. (2019) · iScience · doi:10.1016/j.isci.2019.05.001 · Cited by 179 · see citing works

Nicotinamide Mononucleotide: A Promising Molecule for Therapy of Diverse Diseases by Targeting NAD+ Metabolism

Hong, W., Mo, F., Zhang, Z., Huang, M., & Wei, X. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00246 · Cited by 179 · see citing works

Age-related NAD+ decline

McReynolds, M. R., Chellappa, K., & Baur, J. A. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.110888 · Cited by 169 · see citing works

A glycolytic shift in Schwann cells supports injured axons

Babetto, E., Wong, K. M., & Beirowski, B. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0689-4 · Cited by 163 · see citing works

SARM1 promotes neuroinflammation and inhibits neural regeneration after spinal cord injury through NF-κB signaling

Liu, H., Zhang, J., Xu, X., Lu, S., Yang, D., Xie, C., Jia, M., Zhang, W., Jin, L., Wang, X., et al. (2021) · Theranostics · doi:10.7150/thno.49054 · Cited by 162 · see citing works

Targeting synapse function and loss for treatment of neurodegenerative diseases

Dejanovic, B., Sheng, M., & Hanson, J. E. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00823-1 · Cited by 168 · see citing works

Pharmacological SARM1 inhibition protects axon structure and function in paclitaxel-induced peripheral neuropathy

Bosanac, T., Hughes, R. O., Engber, T. M., Devraj, R. V., Brearley, A., Danker, K., Young, K., Kopatz, J., Hermann, M., Berthemy, A., et al. (2021) · Brain · doi:10.1093/brain/awab184 · Cited by 153 · see citing works

Vincristine and bortezomib use distinct upstream mechanisms to activate a common SARM1-dependent axon degeneration program

Geisler, S., Doan, R. A., Cheng, G., Cetinkaya‐Fisgin, A., Huang, S. X., Höke, A., Milbrandt, J., & DiAntonio, A. (2019) · JCI Insight · doi:10.1172/jci.insight.129920 · Cited by 146 · see citing works

Structural basis of SARM1 activation, substrate recognition, and inhibition by small molecules

Shi, Y. Y., Kerry, P. S., Nanson, J. D., Bosanac, T., Sasaki, Y., Krauss, R., Saikot, F. K., Adams, S. E., Mosaiab, T., Masic, V., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.03.007 · Cited by 146 · see citing works

Shared TIR enzymatic functions regulate cell death and immunity across the tree of life

Essuman, K., Milbrandt, J., Dangl, J. L., & Nishimura, M. T. (2022) · Science · doi:10.1126/science.abo0001 · Cited by 139 · see citing works

The SARM1 axon degeneration pathway: control of the NAD+ metabolome regulates axon survival in health and disease

Figley, M. D., & DiAntonio, A. (2020) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2020.02.012 · Cited by 145 · see citing works

Feeding the brain and nurturing the mind: linking nutrition and the gut microbiota to brain development

Goyal, M. S., Venkatesh, S., Milbrandt, J., Gordon, J. I., & Raichle, M. E. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1511465112 · Cited by 141 · see citing works

Gene therapy targeting SARM1 blocks pathological axon degeneration in mice

Geisler, S., Huang, S. X., Strickland, A., Doan, R. A., Summers, D. W., Mao, X., Park, J., DiAntonio, A., & Milbrandt, J. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20181040 · Cited by 145 · see citing works

MAPK signaling promotes axonal degeneration by speeding the turnover of the axonal maintenance factor NMNAT2

Walker, L. J., Summers, D. W., Sasaki, Y., Brace, E. J., Milbrandt, J., & DiAntonio, A. (2017) · eLife · doi:10.7554/elife.22540 · Cited by 144 · see citing works

Mitochondrial impairment activates the Wallerian pathway through depletion of NMNAT2 leading to SARM1-dependent axon degeneration

Loreto, A., Hill, C. S., Hewitt, V. L., Orsomando, G., Angeletti, C., Gilley, J., Lucci, C., Sanchez-Martinez, A., Whitworth, A. J., Conforti, L., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104678 · Cited by 131 · see citing works

Structural and functional evidence of bacterial antiphage protection by Thoeris defense system via NAD+ degradation

Ka, D., Oh, H., Park, E., Kim, J., & Bae, E. (2020) · Nature Communications · doi:10.1038/s41467-020-16703-w · Cited by 138 · see citing works

SARM1 acts downstream of neuroinflammatory and necroptotic signaling to induce axon degeneration

Ko, K. W., Milbrandt, J., & DiAntonio, A. (2020) · The Journal of Cell Biology · doi:10.1083/jcb.201912047 · Cited by 133 · see citing works

NAD metabolism: Role in senescence regulation and aging

Chini, C. C. S., Cordeiro, H. S., Tran, N. L. K., & Chini, E. N. (2023) · Aging Cell · doi:10.1111/acel.13920 · Cited by 138 · see citing works

SARM1-specific motifs in the TIR domain enable NAD + loss and regulate injury-induced SARM1 activation

Summers, D. W., Gibson, D. A., DiAntonio, A., & Milbrandt, J. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1601506113 · Cited by 135 · see citing works

Structural and Mechanistic Regulation of the Pro-degenerative NAD Hydrolase SARM1

Bratkowski, M. A., Xie, T., Thayer, D. A., Lad, S., Mathur, P., Yang, Y.-S., Danko, G., Burdett, T. C., Danao, J., Cantor, A. J., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107999 · Cited by 132 · see citing works

Structure, biochemical function, and signaling mechanism of plant NLRs

Wang, J., Song, W., & Chai, J. (2022) · Molecular Plant · doi:10.1016/j.molp.2022.11.011 · Cited by 130 · see citing works

Wallerian Degeneration Is Executed by an NMN-SARM1-Dependent Late Ca2+ Influx but Only Modestly Influenced by Mitochondria

Loreto, A., Stefano, M. D., Gering, M., & Conforti, L. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.11.032 · Cited by 128 · see citing works

Oxidative Stress, Neuroinflammation and Mitochondria in the Pathophysiology of Amyotrophic Lateral Sclerosis

Obrador, E., Palmer, R. S., López‐Blanch, R., Jihad-Jebbar, A., Vallés, S. L., & Estrela, J. M. (2020) · Antioxidants · doi:10.3390/antiox9090901 · Cited by 129 · see citing works

Axons Matter: The Promise of Treating Neurodegenerative Disorders by Targeting SARM1-Mediated Axonal Degeneration

Krauss, R., Bosanac, T., Devraj, R. V., Engber, T. M., & Hughes, R. O. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.01.006 · Cited by 125 · see citing works

Structural basis for SARM1 inhibition and activation under energetic stress

Sporny, M., Guez-Haddad, J., Khazma, T., Yaron, A., Dessau, M. A., Shkolnisky, Y., Mim, C., Isupov, M. N., Zalk, R., Hons, M., et al. (2020) · eLife · doi:10.7554/elife.62021 · Cited by 125 · see citing works

Sarm1 Deletion, but Not Wld, Confers Lifelong Rescue in a Mouse Model of Severe Axonopathy

Gilley, J., Ribchester, R. R., & Coleman, M. P. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.09.027 · Cited by 121 · see citing works

Photoreceptor metabolic reprogramming: current understanding and therapeutic implications

Pan, W. W., Wubben, T. J., & Besirli, C. G. (2021) · Communications Biology · doi:10.1038/s42003-021-01765-3 · Cited by 117 · see citing works

Constitutively active SARM1 variants that induce neuropathy are enriched in ALS patients

Bloom, A. J., Mao, X. R., Strickland, A. M., Sasaki, Y., Milbrandt, J., & DiAntonio, A. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00511-x · Cited by 118 · see citing works

cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons

Sasaki, Y., Engber, T. M., Hughes, R. O., Figley, M. D., Wu, T., Bosanac, T., Devraj, R. V., Milbrandt, J., Krauss, R., & DiAntonio, A. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113252 · Cited by 113 · see citing works

Neuroprotection in glaucoma: Mechanisms beyond intraocular pressure lowering

Tribble, J. R., Hui, F., Quintero, H., Hajji, S. E., Bell, K. C., Polo, A. D., & Williams, P. A. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2023.101193 · Cited by 115 · see citing works

Structural basis of NLR activation and innate immune signalling in plants

Maruta, N., Burdett, H., Lim, B. Y. J., Hu, X., Desa, S., Manik, M. K., & Kobe, B. (2022) · Immunogenetics · doi:10.1007/s00251-021-01242-5 · Cited by 110 · see citing works

Interplay between compartmentalized NAD + synthesis and consumption: a focus on the PARP familyPreprint

Cohen, M. S. (2020) · Genes & Development · doi:10.1101/gad.335109.119 · Cited by 109 · see citing works

Biomechanical microenvironment in peripheral nerve regeneration: from pathophysiological understanding to tissue engineering development

Kong, L., Gao, X., Qian, Y., Sun, W., You, Z., & Fan, C. (2022) · Theranostics · doi:10.7150/thno.74571 · Cited by 111 · see citing works

Pharmacological bypass of NAD ⁺ salvage pathway protects neurons from chemotherapy-induced degeneration

Liu, H.-W., Smith, C. B., Schmidt, M. S., Cambronne, X. A., Cohen, M. S., Migaud, M. E., Brenner, C., & Goodman, R. H. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1809392115 · Cited by 105 · see citing works

Structural and Functional Rescue of Chronic Metabolically Stressed Optic Nerves through Respiration

Harun‐Or‐Rashid, M., Pappenhagen, N., Palmer, P. G., Smith, M. A., Gevorgyan, V., Wilson, G. N., Crish, S. D., & Inman, D. M. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.3652-17.2018 · Cited by 105 · see citing works

Axon Death Pathways Converge on Axundead to Promote Functional and Structural Axon Disassembly

Neukomm, L. J., Burdett, T. C., Seeds, A. M., Hampel, S., Coutinho‐Budd, J., Farley, J. E., Wong, J. J. L., Karadeniz, Y. B., Osterloh, J. M., Sheehan, A. E., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.06.031 · Cited by 102 · see citing works

An injectable and adaptable hydrogen sulfide delivery system for modulating neuroregenerative microenvironment

Dong, X., Zhang, H., Duan, P., Liu, K., Yu, Y., Wei, W., Wang, W., Liu, Y., Cheng, Q., Liang, X., et al. (2023) · Science Advances · doi:10.1126/sciadv.adi1078 · Cited by 99 · see citing works

NMN Deamidase Delays Wallerian Degeneration and Rescues Axonal Defects Caused by NMNAT2 Deficiency In Vivo

Stefano, M. D., Loreto, A., Orsomando, G., Mori, V., Zamporlini, F., Hulse, R. P., Webster, J., Donaldson, L. F., Gering, M., Raffaelli, N., et al. (2017) · Current Biology · doi:10.1016/j.cub.2017.01.070 · Cited by 97 · see citing works

Axonal Degeneration in AD: The Contribution of Aβ and Tau

Salvadores, N., Gerónimo‐Olvera, C., & Court, F. A. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.581767 · Cited by 97 · see citing works

SARM1 is a multi-functional NAD(P)ase with prominent base exchange activity, all regulated bymultiple physiologically relevant NAD metabolites

Angeletti, C., Amici, A., Gilley, J., Loreto, A., Trapanotto, A. G., Antoniou, C., Merlini, E., Coleman, M. P., & Orsomando, G. (2022) · iScience · doi:10.1016/j.isci.2022.103812 · Cited by 95 · see citing works

Metabolic Vulnerability in the Neurodegenerative Disease Glaucoma

Inman, D. M., & Harun-Or-Rashid, M. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00146 · Cited by 88 · see citing works

Glutamate excitotoxicity and Ca 2+ -regulation of respiration: Role of the Ca 2+ activated mitochondrial transporters (CaMCs)

Rueda, C. B., Llorente‐Folch, I., Traba, J., Amigo, I., González‐Sánchez, P., Contreras, L., Juaristi, I., Martínez-Valero, P., Pardo, B., del Arco, A., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2016.04.003 · Cited by 94 · see citing works

Efficacy and tolerability of EH301 for amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled human pilot study

de la Rubia, J. E., Drehmer, E., Platero, J. L., Benlloch, M., Caplliure-Llopis, J., Villaron-Casales, C., de Bernardo, N., AlarcÓn, J., Fuente, C., Carrera, S., et al. (2019) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2018.1536152 · Cited by 92 · see citing works

Axonal energy metabolism, and the effects in aging and neurodegenerative diseases

Yang, S., Park, J. H., & Lu, H.-C. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00634-3 · Cited by 94 · see citing works

Mitochondria in Neuronal Health: From Energy Metabolism to Parkinson's Disease

Mahadevan, H. M., Hashemiaghdam, A., Ashrafi, G., & Harbauer, A. B. (2021) · Advanced Biology · doi:10.1002/adbi.202100663 · Cited by 106 · see citing works

Primary Traumatic Axonopathy in Mice Subjected to Impact Acceleration: A Reappraisal of Pathology and Mechanisms with High-Resolution Anatomical Methods

Ziogas, N. K., & Koliatsos, V. E. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.2343-17.2018 · Cited by 90 · see citing works

Axon injury signaling and compartmentalized injury response in glaucoma

Syc‐Mazurek, S. B., & Libby, R. T. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.07.002 · Cited by 90 · see citing works

Mitochondrial Behavior in Axon Degeneration and Regeneration

Wang, B., Huang, M., Shang, D., Yan, X., Zhao, B., & Zhang, X. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.650038 · Cited by 90 · see citing works

Recent Developments of Novel Pharmacologic Therapeutics for Prevention of Chemotherapy-Induced Peripheral Neuropathy

Hu, S., Huang, K. M., Adams, E., Loprinzi, C. L., & Lustberg, M. B. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2152 · Cited by 89 · see citing works

Sarm1 activation produces cADPR to increase intra-axonal Ca++ and promote axon degeneration in PIPN

Li, Y., Pazyra‐Murphy, M. F., Avizonis, D. Z., Russo, M. D. S. T., Tang, S., Chen, C.-Y., Hsueh, Y., Bergholz, J. S., Jiang, T., Zhao, J. J., et al. (2021) · The Journal of Cell Biology · doi:10.1083/jcb.202106080 · Cited by 88 · see citing works

The CD38 glycohydrolase and the NAD sink: implications for pathological conditions

Zeidler, J. D., Hogan, K. A., Agorrody, G., Peclat, T., Kashyap, S., Kanamori, K. S., Gomez, L. S., Mazdeh, D. Z., Warner, G. M., Thompson, K. L., et al. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00451.2021 · Cited by 90 · see citing works

NAMPT as a Therapeutic Target against Stroke

Wang, P., & Miao, C. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.08.012 · Cited by 86 · see citing works

The Influence of Mitochondrial Dynamics and Function on Retinal Ganglion Cell Susceptibility in Optic Nerve Disease

Muench, N. A., Patel, S., Maes, M. E., Donahue, R., Ikeda, A., & Nickells, R. W. (2021) · Cells · doi:10.3390/cells10071593 · Cited by 87 · see citing works

Nicotinamide riboside, a form of vitamin B 3 , protects against excitotoxicity‐induced axonal degeneration

Vaur, P., Brugg, B., Mericskay, M., Li, Z., Schmidt, M. S., Vivien, D., Orset, C., Jacotot, E. D., Brenner, C., & Duplus, E. (2017) · The FASEB Journal · doi:10.1096/fj.201700221rr · Cited by 86 · see citing works

Reconnecting Eye to Brain

Crair, M. C., & Mason, C. A. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1711-16.2016 · Cited by 86 · see citing works

Palmitoylation enables MAPK-dependent proteostasis of axon survival factors

Summers, D. W., Milbrandt, J., & DiAntonio, A. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1806933115 · Cited by 84 · see citing works

SARM1 signaling mechanisms in the injured nervous system

Sambashivan, S., & Freeman, M. R. (2021) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2021.05.004 · Cited by 46 · see citing works

SARM1-specific motifs in the TIR domain enable NAD + loss and regulate injury-induced SARM1 activation

Summers, D. W., Gibson, D. A., DiAntonio, A., & Milbrandt, J. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1601506113 · Cited by 135 · see citing works

The SARM1 toll/interleukin-1 receptor domain possesses intrinsic NAD(+) cleavage activity that promotes pathological axonal degeneration

Essuman, K., Summers, D. W., Sasaki, Y., Mao, X., DiAntonio, A., & Milbrandt, J. (2017) · Neuron · doi:10.1016/j.neuron.2017.02.022 · Cited by 619 · see citing works

TIR Axons Apart: Unpredicted NADase Controls Axonal Degeneration

Goldner, R., & Yaron, A. (2017) · Neuron · doi:10.1016/j.neuron.2017.03.005 · Cited by 4 · see citing works

SARM1: The Checkpoint of Axonal Degeneration in the Nervous System Disorders

Karnik, A., & Joshi, A. R. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04835-3 · Cited by 11 · see citing works